News|Videos|September 12, 2025

David Brousseau, MD: Benefits of timely opioid dosing for SCD pain

Name: David Brousseau, MD: Benefits of timely opioid doseing for SCD pain
Uploaded: 2025-09-12T17:35:10.761Z
Duration: PT6m8S
Description: Study author David Brousseau, MD, MS, explains the benefit of a child being able to go home after a sickle cell disease-associated ED visit.

Author(s)David Brousseau, MD, MS

Fact checked by: Joshua Fitch, Senior Editor

Study author David Brousseau, MD, MS, explains the benefit of a child being able to go home after a sickle cell disease-associated ED visit.

Children with sickle cell disease (SCD) experiencing acute pain episodes may avoid hospitalization when opioids are administered promptly in the emergency department (ED), according to a recent multisite study published in JAMA Pediatrics and discussed further by study author David Brousseau, MD, MS, pediatrician-in-chief and director of Research at Nemours Children’s Health.^1,2